Application Of Epirubicin Within A Neo-/Adjuvant Chemotherapy In Patients With Primary Breast Cancer

Clinical trial NCT01061359 · COMPLETED

Trial details

NCT number: NCT01061359
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Breast Neoplasm

Start date: 1999-01-01
Primary completion: 2009-10-01
Enrollment: 1981

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.